Copyright Reports & Markets. All rights reserved.

Global Hemoglobinopathies Drugs Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Hemoglobinopathies Drugs

      • 1.1 Definition of Hemoglobinopathies Drugs
      • 1.2 Hemoglobinopathies Drugs Segment by Type
        • 1.2.1 Global Hemoglobinopathies Drugs Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Thalassemia Therapy
        • 1.2.3 Sickle Cell Disease(SCD) Therapy
        • 1.2.4 Other Therapy
      • 1.3 Hemoglobinopathies Drugs Segment by Applications
        • 1.3.1 Global Hemoglobinopathies Drugs Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Alpha Thalassemia
        • 1.3.3 Beta thalassemia
        • 1.3.4 Sickle Cell Disease
        • 1.3.5 Hb Variants Diseases
      • 1.4 Global Hemoglobinopathies Drugs Overall Market
        • 1.4.1 Global Hemoglobinopathies Drugs Revenue (2014-2025)
        • 1.4.2 Global Hemoglobinopathies Drugs Production (2014-2025)
        • 1.4.3 North America Hemoglobinopathies Drugs Status and Prospect (2014-2025)
        • 1.4.4 Europe Hemoglobinopathies Drugs Status and Prospect (2014-2025)
        • 1.4.5 China Hemoglobinopathies Drugs Status and Prospect (2014-2025)
        • 1.4.6 Japan Hemoglobinopathies Drugs Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Hemoglobinopathies Drugs Status and Prospect (2014-2025)
        • 1.4.8 India Hemoglobinopathies Drugs Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Hemoglobinopathies Drugs
      • 2.3 Manufacturing Process Analysis of Hemoglobinopathies Drugs
      • 2.4 Industry Chain Structure of Hemoglobinopathies Drugs

      3 Development and Manufacturing Plants Analysis of Hemoglobinopathies Drugs

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Hemoglobinopathies Drugs Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Hemoglobinopathies Drugs
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Hemoglobinopathies Drugs Production and Capacity Analysis
      • 4.2 Hemoglobinopathies Drugs Revenue Analysis
      • 4.3 Hemoglobinopathies Drugs Price Analysis
      • 4.4 Market Concentration Degree

      5 Hemoglobinopathies Drugs Regional Market Analysis

      • 5.1 Hemoglobinopathies Drugs Production by Regions
        • 5.1.1 Global Hemoglobinopathies Drugs Production by Regions
        • 5.1.2 Global Hemoglobinopathies Drugs Revenue by Regions
      • 5.2 Hemoglobinopathies Drugs Consumption by Regions
      • 5.3 North America Hemoglobinopathies Drugs Market Analysis
        • 5.3.1 North America Hemoglobinopathies Drugs Production
        • 5.3.2 North America Hemoglobinopathies Drugs Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Hemoglobinopathies Drugs Import and Export
      • 5.4 Europe Hemoglobinopathies Drugs Market Analysis
        • 5.4.1 Europe Hemoglobinopathies Drugs Production
        • 5.4.2 Europe Hemoglobinopathies Drugs Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Hemoglobinopathies Drugs Import and Export
      • 5.5 China Hemoglobinopathies Drugs Market Analysis
        • 5.5.1 China Hemoglobinopathies Drugs Production
        • 5.5.2 China Hemoglobinopathies Drugs Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Hemoglobinopathies Drugs Import and Export
      • 5.6 Japan Hemoglobinopathies Drugs Market Analysis
        • 5.6.1 Japan Hemoglobinopathies Drugs Production
        • 5.6.2 Japan Hemoglobinopathies Drugs Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Hemoglobinopathies Drugs Import and Export
      • 5.7 Southeast Asia Hemoglobinopathies Drugs Market Analysis
        • 5.7.1 Southeast Asia Hemoglobinopathies Drugs Production
        • 5.7.2 Southeast Asia Hemoglobinopathies Drugs Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Hemoglobinopathies Drugs Import and Export
      • 5.8 India Hemoglobinopathies Drugs Market Analysis
        • 5.8.1 India Hemoglobinopathies Drugs Production
        • 5.8.2 India Hemoglobinopathies Drugs Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Hemoglobinopathies Drugs Import and Export

      6 Hemoglobinopathies Drugs Segment Market Analysis (by Type)

      • 6.1 Global Hemoglobinopathies Drugs Production by Type
      • 6.2 Global Hemoglobinopathies Drugs Revenue by Type
      • 6.3 Hemoglobinopathies Drugs Price by Type

      7 Hemoglobinopathies Drugs Segment Market Analysis (by Application)

      • 7.1 Global Hemoglobinopathies Drugs Consumption by Application
      • 7.2 Global Hemoglobinopathies Drugs Consumption Market Share by Application (2014-2019)

      8 Hemoglobinopathies Drugs Major Manufacturers Analysis

      • 8.1 Gamida Cell
        • 8.1.1 Gamida Cell Hemoglobinopathies Drugs Production Sites and Area Served
        • 8.1.2 Gamida Cell Product Introduction, Application and Specification
        • 8.1.3 Gamida Cell Hemoglobinopathies Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Alnylam Pharmaceuticals
        • 8.2.1 Alnylam Pharmaceuticals Hemoglobinopathies Drugs Production Sites and Area Served
        • 8.2.2 Alnylam Pharmaceuticals Product Introduction, Application and Specification
        • 8.2.3 Alnylam Pharmaceuticals Hemoglobinopathies Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Biogen Idec
        • 8.3.1 Biogen Idec Hemoglobinopathies Drugs Production Sites and Area Served
        • 8.3.2 Biogen Idec Product Introduction, Application and Specification
        • 8.3.3 Biogen Idec Hemoglobinopathies Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Sangamo BioSciences Inc.
        • 8.4.1 Sangamo BioSciences Inc. Hemoglobinopathies Drugs Production Sites and Area Served
        • 8.4.2 Sangamo BioSciences Inc. Product Introduction, Application and Specification
        • 8.4.3 Sangamo BioSciences Inc. Hemoglobinopathies Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Genetix Pharmaceuticals/Bluebird Bio
        • 8.5.1 Genetix Pharmaceuticals/Bluebird Bio Hemoglobinopathies Drugs Production Sites and Area Served
        • 8.5.2 Genetix Pharmaceuticals/Bluebird Bio Product Introduction, Application and Specification
        • 8.5.3 Genetix Pharmaceuticals/Bluebird Bio Hemoglobinopathies Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Global Blood Therapeutics Inc.
        • 8.6.1 Global Blood Therapeutics Inc. Hemoglobinopathies Drugs Production Sites and Area Served
        • 8.6.2 Global Blood Therapeutics Inc. Product Introduction, Application and Specification
        • 8.6.3 Global Blood Therapeutics Inc. Hemoglobinopathies Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Pfizer Inc.
        • 8.7.1 Pfizer Inc. Hemoglobinopathies Drugs Production Sites and Area Served
        • 8.7.2 Pfizer Inc. Product Introduction, Application and Specification
        • 8.7.3 Pfizer Inc. Hemoglobinopathies Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Mast Therapeutics
        • 8.8.1 Mast Therapeutics Hemoglobinopathies Drugs Production Sites and Area Served
        • 8.8.2 Mast Therapeutics Product Introduction, Application and Specification
        • 8.8.3 Mast Therapeutics Hemoglobinopathies Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Emmaus Life Sciences, Inc.
        • 8.9.1 Emmaus Life Sciences, Inc. Hemoglobinopathies Drugs Production Sites and Area Served
        • 8.9.2 Emmaus Life Sciences, Inc. Product Introduction, Application and Specification
        • 8.9.3 Emmaus Life Sciences, Inc. Hemoglobinopathies Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Prolong Pharmaceuticals
        • 8.10.1 Prolong Pharmaceuticals Hemoglobinopathies Drugs Production Sites and Area Served
        • 8.10.2 Prolong Pharmaceuticals Product Introduction, Application and Specification
        • 8.10.3 Prolong Pharmaceuticals Hemoglobinopathies Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 Celgene Corporation
      • 8.12 HemaQuest Pharmaceuticals

      9 Development Trend of Analysis of Hemoglobinopathies Drugs Market

      • 9.1 Global Hemoglobinopathies Drugs Market Trend Analysis
        • 9.1.1 Global Hemoglobinopathies Drugs Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Hemoglobinopathies Drugs Regional Market Trend
        • 9.2.1 North America Hemoglobinopathies Drugs Forecast 2019-2025
        • 9.2.2 Europe Hemoglobinopathies Drugs Forecast 2019-2025
        • 9.2.3 China Hemoglobinopathies Drugs Forecast 2019-2025
        • 9.2.4 Japan Hemoglobinopathies Drugs Forecast 2019-2025
        • 9.2.5 Southeast Asia Hemoglobinopathies Drugs Forecast 2019-2025
        • 9.2.6 India Hemoglobinopathies Drugs Forecast 2019-2025
      • 9.3 Hemoglobinopathies Drugs Market Trend (Product Type)
      • 9.4 Hemoglobinopathies Drugs Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Hemoglobinopathies Drugs Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global Hemoglobinopathies Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on Hemoglobinopathies Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hemoglobinopathies Drugs market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Hemoglobinopathies Drugs in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Hemoglobinopathies Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Gamida Cell
        Alnylam Pharmaceuticals
        Biogen Idec
        Sangamo BioSciences Inc.
        Genetix Pharmaceuticals/Bluebird Bio
        Global Blood Therapeutics Inc.
        Pfizer Inc.
        Mast Therapeutics
        Emmaus Life Sciences, Inc.
        Prolong Pharmaceuticals
        Celgene Corporation
        HemaQuest Pharmaceuticals

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Thalassemia Therapy
        Sickle Cell Disease(SCD) Therapy
        Other Therapy

        Segment by Application
        Alpha Thalassemia
        Beta thalassemia
        Sickle Cell Disease
        Hb Variants Diseases

        Buy now